Product Information
DEXTROAMP-AMPHET ER 15 MG CAP is a generic product labeled by Sun Pharmaceutical Industries Inc., priced at $0.5548 per EA under NDC 57664033888. Its NADAC has been published 285 times since Sep 9, 2020.
FDA first approved this application on May 17, 2019.
DEXTROAMP-AMPHET ER 15 MG CAP
Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate, Amphetamine SulfateStrength
3.75; 3.75; 3.75; 3.75 mg/1; mg/1; mg/1; mg/1
Manufacturer
Sun Pharmaceutical Industries Inc.NDC
57664033888
Classification
Generic
Dosage Form
CAPSULE, EXTENDED RELEASE
Route
ORAL
Effective Date
2/18/2026
Active Ingredients
AMPHETAMINE ASPARTATE MONOHYDRATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATEApproval Type
Generic (ANDA)
FDA Application
ANDA211715FDA Approved
5/17/2019
On Market Since
3/5/2020
Pharmacological Classes
Price Statistics
The NADAC for DEXTROAMP-AMPHET ER 15 MG CAP has been published 285 times since Sep 9, 2020, and over the history we have for it it has declined 65.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.5548 per EA |
|---|---|
| All-time high | $1.6220 (Sep 16, 2020) |
| All-time low | $0.4362 (May 22, 2024) |
| 52-week high | $0.5766 |
| 52-week low | $0.5015 |
| Median price | $0.6062 |
| Average price | $0.6382 |
| Largest weekly change | +45.9% (Aug 21, 2024) |
| Weeks tracked | 285 |
| Tracking since | Sep 9, 2020 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
-3.8%
3Y
-9.2%
5Y
-31.7%
All
-65.8%
Last surveyed Feb 18, 2026 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of DEXTROAMP-AMPHET ER 15 MG CAP?
The current National Average Drug Acquisition Cost (NADAC) for DEXTROAMP-AMPHET ER 15 MG CAP, manufactured by Sun Pharmaceutical Industries Inc., is $0.5548 per EA (NDC 57664033888), effective Feb 18, 2026.
How has the price of DEXTROAMP-AMPHET ER 15 MG CAP changed over time?
Over the history we have for it, the NADAC for DEXTROAMP-AMPHET ER 15 MG CAP has declined 65.8%. It has been tracked across 285 weekly CMS publications since Sep 9, 2020.
What are the highest and lowest recorded NADAC prices for DEXTROAMP-AMPHET ER 15 MG CAP?
Since Sep 9, 2020, the NADAC for DEXTROAMP-AMPHET ER 15 MG CAP has ranged from a low of $0.4362 (May 22, 2024) to a high of $1.6220 (Sep 16, 2020), with a median of $0.6062 per EA.
Are there cheaper alternatives to DEXTROAMP-AMPHET ER 15 MG CAP?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as DEXTROAMP-AMPHET ER 15 MG CAP in a comparable dosage form, but none are currently priced below it.
Who manufactures DEXTROAMP-AMPHET ER 15 MG CAP?
DEXTROAMP-AMPHET ER 15 MG CAP (NDC 57664033888) is labeled by Sun Pharmaceutical Industries Inc., and CMS classifies it as a generic product.